Trial Profile
A dose Finding Study of the Efficacy of LAIS Grass tablets in patients suffering from grass pollen-induced allergic rhinoconjunctivitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2013
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic rhinitis; Allergic rhinoconjunctivitis
- Focus Therapeutic Use
- Acronyms SMART5
- 17 Sep 2013 New trial record